share_log

Belgravia Hartford Capital Inc. Provides Corporate Update

Belgravia Hartford Capital Inc. Provides Corporate Update

贝尔格拉维亚哈特福德资本公司提供企业更新
newsfile ·  08/15 08:34

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - BELGRAVIA HARTFORD CAPITAL INC. (CSE: BLGV) ("Belgravia Hartford", "Belgravia" or the "Company") is pleased to announce the appointment of Ms. Ava Tahmasebi as an independent director to the Board of the Company. Additionally, Dr. Shoaib Sheikh has been appointed as head of the company's advisory committee.

安大略省多伦多-(资讯公司-2024年8月15日)-BELGRAVIA HARTFORD CAPITAL INC。(CSE: BLGV)(“Belgravia Hartford”,“Belgravia”或“公司”)很高兴地宣布任命Ms. Ava Tahmasebi为该公司的独立董事。此外,Dr. Shoaib Sheikh也被任命为公司咨询委员会的负责人。

Ms. Ava Tahmasebi is a seasoned executive with over a decade of experience in driving innovation and business growth within the startup ecosystem. She holds a Doctor of Philosophy (Ph.D.) in Wireless Networks and has recently updated her skills through a Data Analytics program at the University of Toronto. Ms. Tahmasebi has played a pivotal role in mentoring over 50 startups, steering them towards notable success. As CEO of Startup Station, a Toronto-based startup studio with a focus on women entrepreneurs, she has refined her expertise in transforming nascent ideas into successful, market-ready businesses. Startup Station is a member of the National Angel Capital Organization (NACO).

Ava Tahmasebi女士是一名经验丰富的高管,拥有十多年的创业生态系统创新和业务增长经验。她拥有无线网络的哲学博士学位,并最近通过多伦多大学的数据分析计划更新了她的技能。Tahmasebi女士在指导50多个初创企业方面发挥了关键作用,引导它们取得了显着的成功。作为位于多伦多的Startup Station的首席执行官,该公司专注于女性企业家,她在将新生的想法转化为成功的市场就绪业务方面提高了她的专业知识。Startup Station是National Angel Capital组织(NACO)的成员。

Dr. Shoaib Sheikh, MD, FACS, is a surgeon who has served on multiple provincial, national and international boards and committees for the past 17 years. The nature of involvement has been from board of directors, executive committees, editorial boards and provincial review committees. Dr. Sheikh has served for two full terms on the Board of Governors of the American College of Surgeons which has 90,000 member surgeons and has served on the finance committee of the College of Surgeons. Dr. Shiekh also owns 8,414,095 common shares of Belgravia Hartford which represents 12.49% of the outstanding common shares of the Company.

Shoaib Sheikh医学博士,FACS,是一名外科医生,服务于多个省级、国家和国际委员会。参与性质涉及董事会、执行委员会、编辑委员会和省级审查委员会。Sheikh医生在美国外科医生学院的董事会上连任两届,该医院拥有9万名会员外科医生,并曾在外科医院的财务委员会任职。Shiekh医生还拥有Belgravia Hartford的8414095股普通股,占公司流通普通股的12.49%。

Mr. Mehdi Azodi, The CEO & President of Belgravia stated "The addition of Ms. Tahmasebi to the board strengthens the governance and adds fresh perspective on future investments and due diligence process. The appointment of Dr. Sheikh provides the board and legal team with global business experience and access to capital injection for the company to build out a new business platform and fund the company's litigation affairs."

Belgravia的CEO和总裁Mehdi Azodi表示:“任命Tahmasebi女士加强了公司的治理,并为未来的投资和尽职调查流程提供了新的视角。任命Sheikh博士为董事会提供了全球商业经验和向公司注入资本以建立新业务平台和资助公司诉讼事务的途径。”

About Belgravia Hartford

关于Belgravia Hartford

Belgravia Hartford Capital Inc. ("Belgravia" or the "Company") is a publicly traded investment holding company listed on the Canadian Securities Exchange. Belgravia is focused on growing its assets and holdings and increasing its net asset value (NAV). Belgravia invests in a portfolio of private and public companies located in jurisdictions governed by the rule of law. It takes a multi-sector investment approach with emphasis in the resources and commodities sector. Belgravia and its investments are considered high risk holdings and it may expose shareholders to significant volatility and losses.

Belgravia Hartford Capital Inc.(“Belgravia”或“公司”)是一家在加拿大证券交易所上市的公共投资控股公司。Belgravia专注于增长其资产和持股,并增加其净资产价值(NAV)。Belgravia在受法治管辖的地区的私人和公共公司组合中采取多部门投资方法,重点放在资源和商品领域。Belgravia及其投资被认为是高风险持股,可能使股东面临重大波动和损失。

For more information, please visit

有关更多信息,请访问

Forward-Looking Statements

前瞻性声明

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, the timing for completion of research and development activities, the potential value of royalties, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by the Company, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

本新闻稿中提供的某些信息可能包含涉及实质性已知和未知风险和不确定性以及可能导致公司实际结果、表现或成果与任何未来结果、表现或成果相差极大的其他因素。前瞻性声明包括使用前瞻性术语的声明,如“可能”,“将”,“期望”,“预期”,“相信”,“继续”,“潜力”或其他变体或可比术语的声明。这些前瞻性声明包括但不限于计划的投资活动及相关收益、完成研究和开发活动的时间、版税的潜在价值及其他非历史事实的声明。这些前瞻性声明受到众多风险和不确定性的影响,其中一些风险和不确定性超出了公司的控制范围,包括但不限于市场趋势的变化、公司进行研究所涉及的完成、结果和时间、资源资产的风险、一般经济条件的影响、大宗商品价格、行业条件、对规制、环境和政府批准的依赖以及获取额外融资的不确定性。读者被警告,在为该信息进行准备时使用的假设虽然在准备时被认为是合理的,但可能被证明是不准确的,因此不应过度依赖前瞻性声明。

For More Information, Please Contact:
Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca

欲了解更多信息,请联系Mehdi Azodi,董事长兼首席执行官。
Mehdi Azodi,总裁兼首席执行官
贝尔格拉维亚哈特福德资本公司。
(416) 779-3268
mazodi@blgv.ca

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发